Home
About
Overview
Sharing Data
ORCID
Help
History (96)
ras GTPase-Activating Proteins
Identification of t(15;17) and a segmental duplication of chromosome 11q23 in a patient with acute myeloblastic leukemia M2.
Leukemia-Lymphoma, Adult T-Cell
Regulation of the biphasic decline in scleral proteoglycan synthesis during the recovery from induced myopia.
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
See All 96 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study. Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619886022.
View in:
PubMed
subject areas
Administration, Oral
Aged
Anticoagulants
Double-Blind Method
Factor Xa Inhibitors
Female
Humans
Middle Aged
Risk Factors
Rivaroxaban
Venous Thromboembolism
authors with profiles
Gary E Raskob